-71.4%
SOUN vs MRNA
+945.0%
-1,016.5%
-74.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +4.9% | +13.1% | -8.3% | +4.3% |
| 7D | -2.7% | +20.6% | -23.3% | -3.5% |
| 30D | -26.5% | +27.1% | -53.7% | -27.3% |
| 3M | -33.6% | +353.4% | -387.0% | -39.9% |
| 6M | -54.4% | +446.3% | -500.6% | -60.5% |
| YTD | -56.7% | +776.2% | -832.8% | -66.1% |
| 1Y | -71.4% | +987.9% | -1,059.4% | -78.8% |
| All | -71.4% | +945.0% | -1,016.5% | -78.8% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling